Abstract ES10-2: Understanding breast cancer using a developmental perspective
GM Wahl(Salk Institute for Biological Studies), K-T Varley(University of Utah), Sebastian Preißl(University of Graz), Ozlen Balcioglu(University of Utah), RT Giraddi(Salk Institute for Biological Studies), NE Lytle(Salk Institute for Biological Studies), Jae Yeon Hwang(University of Utah), Gidsela Luna(University of California San Diego), CL Trejo(Salk Institute for Biological Studies), Chi‐Yeh Chung(Salk Institute for Biological Studies), Richard E. Heinz(University of Utah), Jaslem Herrera-Valdez(Salk Institute for Biological Studies), Roger S. Lasken(J. Craig Venter Institute), Christopher Dravis(Salk Institute for Biological Studies), Tannishtha Reya(Columbia University Irving Medical Center), Zhibo Ma(Salk Institute for Biological Studies), Olivier Poirion(Jackson Laboratory), Bin Ren(Southwest Jiaotong University), Xiaomeng Hou(University of California San Diego), Mark Novotny(Salk Institute for Biological Studies), BT Spike(University of Utah), Cheng Fan(University of North Carolina at Chapel Hill), Berhane M. Hagos(University of Utah), CM Perou(University of North Carolina at Chapel Hill), EM Mehrabad(University of Utah)
Cited by 0
Related Papers
Stem cells, cancer, and cancer stem cells
|Nature|2001|9.7k
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
|Breast Cancer Research|2010|2.1k
The molecular portraits of breast tumors are conserved across microarray platforms
|BMC Genomics|2006|1.5k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k